Rodriguez Almaraz E, Guerra G, Al-Adli N, Young J, Dada A, Quintana D
Neurooncol Adv. 2025; 7(1):vdaf024.
PMID: 40051658
PMC: 11883348.
DOI: 10.1093/noajnl/vdaf024.
Huong Q, Truc L, Ueda H, Fukui K, Higasa K, Sato Y
Biomedicines. 2025; 13(1).
PMID: 39857711
PMC: 11763285.
DOI: 10.3390/biomedicines13010127.
Drobek A, Bernaleau L, Delacretaz M, Calderon Copete S, Royer-Chardon C, Longepierre M
Nat Commun. 2025; 16(1):967.
PMID: 39856058
PMC: 11759703.
DOI: 10.1038/s41467-024-55692-y.
Hino U, Tamura R, Toda M
Ther Clin Risk Manag. 2025; 21():61-68.
PMID: 39839825
PMC: 11748755.
DOI: 10.2147/TCRM.S362794.
Koo H, Park K, Sohn H, Kang M, Kim D, Park Z
Nat Commun. 2025; 16(1):628.
PMID: 39819877
PMC: 11739382.
DOI: 10.1038/s41467-024-54476-8.
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.
Wang Y, Zhang Y, Luo H, Wei W, Liu W, Wang W
Acta Pharm Sin B. 2025; 14(12):5235-5248.
PMID: 39807309
PMC: 11725127.
DOI: 10.1016/j.apsb.2024.08.019.
Motif-guided identification of KRAS-interacting proteins.
Wu S, Gao X, Wu D, Liu L, Yao H, Meng X
BMC Biol. 2024; 22(1):264.
PMID: 39563372
PMC: 11575137.
DOI: 10.1186/s12915-024-02067-w.
Concerted transcriptional regulation of the morphogenesis of hypothalamic neurons by ONECUT3.
Zupancic M, Keimpema E, Tretiakov E, Eder S, Lev I, Englmaier L
Nat Commun. 2024; 15(1):8631.
PMID: 39366958
PMC: 11452682.
DOI: 10.1038/s41467-024-52762-z.
Dysregulation of RAS proteostasis by autosomal-dominant LZTR1 mutation induces Noonan syndrome-like phenotypes in mice.
Abe T, Morisaki K, Niihori T, Terao M, Takada S, Aoki Y
JCI Insight. 2024; 9(22).
PMID: 39352760
PMC: 11601938.
DOI: 10.1172/jci.insight.182382.
LZTR1 loss-of-function variants associated with café au lait macules with or without freckling.
Horn S, Neuhann T, Hennig C, Abad-Perez A, Prott E, Cardellini L
Front Neurol. 2024; 15:1391425.
PMID: 39258154
PMC: 11383758.
DOI: 10.3389/fneur.2024.1391425.
Correspondence to editorial on "KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression".
Lee S, Kim K
Clin Mol Hepatol. 2024; 31(1):e78-e80.
PMID: 39253744
PMC: 11791590.
DOI: 10.3350/cmh.2024.0750.
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on "KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression".
Leung R, Lee T
Clin Mol Hepatol. 2024; 31(1):304-307.
PMID: 39218444
PMC: 11791552.
DOI: 10.3350/cmh.2024.0718.
Identification and Characterization of Novel Small-Molecule Enhancers of the CUL3 E3 Ligase KRAS Complex.
Piech S, Bruschweiler S, Westphalen J, Siess K, Garcia Murias J, Konrat R
ACS Chem Biol. 2024; 19(9):1942-1952.
PMID: 39194017
PMC: 11420953.
DOI: 10.1021/acschembio.4c00077.
KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression.
Jung Y, Lee Y, Dao T, Jung K, Yu J, Oh A
Clin Mol Hepatol. 2024; 30(4):895-913.
PMID: 39098817
PMC: 11540369.
DOI: 10.3350/cmh.2024.0364.
Phenotypic Expansion of Autosomal Dominant -Related Disorders with Special Emphasis on Adult-Onset Features.
Uliana V, Ambrosini E, Taiani A, Cesarini S, Cannizzaro I, Negrotti A
Genes (Basel). 2024; 15(7.
PMID: 39062695
PMC: 11276570.
DOI: 10.3390/genes15070916.
Low protein expression of LZTR1 in hepatocellular carcinoma triggers tumorigenesis activating the RAS/RAF/MEK/ERK signaling.
Ye G, Wang J, Xia J, Zhu C, Gu C, Li X
Heliyon. 2024; 10(12):e32855.
PMID: 38994114
PMC: 11237970.
DOI: 10.1016/j.heliyon.2024.e32855.
Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Li X, Li W, Zhang Y, Xu L, Song Y
Genes Dis. 2024; 11(5):101150.
PMID: 38947742
PMC: 11214299.
DOI: 10.1016/j.gendis.2023.101150.
Analysis of copy number variants detected by sequencing in spontaneous abortion.
Liu A, Zhou L, Huang Y, Peng D
Mol Cytogenet. 2024; 17(1):13.
PMID: 38764094
PMC: 11103966.
DOI: 10.1186/s13039-024-00683-3.
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.
Rodriguez-Martin M, Baez-Flores J, Ribes V, Isidoro-Garcia M, Lacal J, Prieto-Matos P
Biomedicines. 2024; 12(4).
PMID: 38672195
PMC: 11048513.
DOI: 10.3390/biomedicines12040841.
Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
Stellacci E, Carter J, Pannone L, Stevenson D, Moslehi D, Venanzi S
Am J Med Genet A. 2024; 194(8):e63627.
PMID: 38613168
PMC: 11223960.
DOI: 10.1002/ajmg.a.63627.